Kazakhstan to vaccinate 3,000 volunteers with domestic QazCovid-in
TARAZ. KAZINFORM Kazakh Prime Minister Askar Mamin visited the biological safety problems research institute of the Kazakh Healthcare Ministry in Zhambyl region.
The research institute completed the I and II stages of the clinical trials of the locally made vaccine QazCovid-in. preliminary results of the trials show high safety, immunological potency and vaccine efficacy of 96%, the PM’s official website reads.
Today the first volunteers were vaccinated at the research institute, hospitals of Almaty and Taraz. 3,000 volunteers will be vaccinated by the end of December. The necessary batch of vaccine up to 10,000 doses was produced. The mass vaccination will start next March.
The PM surveyed progress of constriction of the biopharmaceutical plant for the production of vaccines. It is expected to put it into operation next March. It is supposed to produce 60 mln doses a year.
- Round table on inter-faith accord held in Riyadh
- Vincenzo Nibali returns to Team Astana
- EBRD contributes to improved connectivity in Central Asia
- QazVac vaccine effective against Delta COVID strain, says developer
-
2022 Winter Olympics likely to be held without spectators in attendance — IIHF chief Fasel
-
Eta COVID-19 strain confirmed in 5yo in Pavlodar
- Speeches of the President of the Republic of Kazakhstan
- President's Address to the Nation
- Development of the President's Message
- Foreign Mass Media about Kazakhstan
- World and Crisis